Aripiprazole Tablets USP, Rx only, 30 mg, 30 tablets
Recalled by Ajanta Pharma USA Inc
Class II — moderate
Using this product might cause a temporary or medically reversible health problem. The chance of serious harm is low.
Ajanta Pharma USA Inc has recalled Aripiprazole Tablets USP, Rx only, 30 mg, 30 tablets, according to data published by the U.S. Food and Drug Administration (FDA). The recall was reported on June 24, 2026 and was initiated on May 27, 2026. It is classified as a Class II recall, which means using this product might cause a temporary or medically reversible health problem. The chance of serious harm is low.
Below is a plain-English summary of what was recalled, why it was recalled, how to tell whether you have the affected product, and what steps you can take. For the complete and most current details, you can view the FDA record linked further down this page.
What was recalled?
This recall covers Aripiprazole Tablets USP, Rx only, 30 mg, 30 tablets, with approximately 6,143 bottles affected. The company behind the recall is Ajanta Pharma USA Inc, based in Bridgewater, NJ. The FDA describes the product as: “Aripiprazole Tablets USP, Rx only, 30 mg, 30 tablets, Marketed by: Ajanta Pharma USA Inc., Bridgewater, NJ 08807, Made in India, NDC 27241-056-03.”
Why was Aripiprazole Tablets USP, Rx only, 30 mg, 30 tablets recalled?
According to the FDA, the stated reason for the recall is: “Product Mix-Up: A bottle containing Voriconazole Tablets 50 mg was labelled and distributed as Aripiprazole Tablets USP 30 mg.”
What should you do?
If you think you may have bought Aripiprazole Tablets USP, Rx only, 30 mg, 30 tablets, compare it against the product description and identifying codes (Lot: PA00805, expires: 01/31/2029) before using it. This recall is currently listed as ongoing.
The general guidance for a matching product is to stop using it and follow the instructions in the official FDA recall notice, which may include a repair, replacement, refund, or safe disposal. When in doubt, contact Ajanta Pharma USA Inc or your local health authority.
About this recall
This recall was distributed in NJ. RecallRadar summarizes recall information from public FDA data to make it easier to understand. We are an independent service and are not affiliated with the FDA or any government agency, so please always refer to the official source for the authoritative record — and note the “last synced” date shown on this page, since recall details can change over time.
Full recall details
- Status
- Ongoing
- Date reported
- June 24, 2026
- Recall started
- May 27, 2026
- Distributed in
- NJ
What you can do
Check whether any product you have matches the description and codes above. If it does, stop using it and follow the instructions in the official recall notice. When in doubt, contact the company or your local health authority.
Quick answers
Why was Aripiprazole Tablets USP, Rx only, 30 mg, 30 tablets recalled?+
According to the FDA: Product Mix-Up: A bottle containing Voriconazole Tablets 50 mg was labelled and distributed as A…
How serious is this recall?+
Class II — moderate. Using this product might cause a temporary or medically reversible health problem. The chance of serious harm is low.
What should I do if I have Aripiprazole Tablets USP, Rx only, 30 mg, 30 tablets?+
Compare your product against the description and identifying codes on this page. If it matches, stop using it and follow the instructions in the official recall notice — this usually means returning it for a refund or discarding it. When in doubt, contact the company or your local health authority.
Opens the U.S. Food and Drug Administration (FDA) data for this recall.
Recall number: D-0594-2026. Information last synced from the FDA on July 5, 2026.